Abstract
A ten-year retrospective study is presented of the clinico-pathological features and assessment of therapeutic measures adopted in 121 cases of prostatic carcinoma in a developing country without facilities for radiotherapy. Based on this a therapeutic regimen is suggested.
Similar content being viewed by others
References
Yeboah, E. D., Quartely, J. K. M.: Low dosage stilboestrol in the management of carcinoma of the prostate.Ghana M. J. 16, 13 (1977).
Jackson, M. A. et al.: Characterization of Prostatic Carcinoma Among Blacks. 73rd Annual Meeting of the American Urological Association, 1978.
Steiner, P.: Cancer Race and Geography. Williams & Wiilkins Co., Baltimore, 1954.
United States Public Health Monograph No. 56, 1959.
Barnes, R. W.: Carcinoma of the prostate: a comparative study of modes of treatment.J. Urol., 44, 169 (1940).
The Veterans Administration Co-operative Urological Research Group: The treatment and survival of patients with cancer of the prostate.Surg. Gynaec. Obstet. 124, 1011 (1967).
Nesbit and Baum: Serum phosphatase determinations in diagnosis of prostatic cancer: a review of 1150 cases.J. A. M. A., 145, 1321 (1951).
Blackard, C. E. et al.: Incidence of cardiovascular disease and death in patients receiving diethyl-stilboestrol for carcinoma of the prostate.Cancer, 26, 249 (1970).
Barnes, R. W et al.: Early prostatic cancer—long-term results with conservative treatment.J. Urol.,102, 88 (1969).
Giltestein, V. A.: Cancer of the prostate gland. Results of early diagnosis and therapy undertaken for cure of the disease.J. A. M. A., 215, 81 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Udeh, F.N. Prostatic carcinoma in Nigeria. International Urology and Nephrology 13, 159–166 (1981). https://doi.org/10.1007/BF02082060
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082060